| Autor: |
Gupta N; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Case Western Reserve University School of Medicine, Cleveland, Ohio., Virgen CA; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Goyal A; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Lane AA; Harvard Medical School, Boston, Massachusetts.; Blastic Plasmacytoid Dendritic Cell Neoplasm Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Antin JH; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology Stem Cell Transplantation Program, Dana-Farber Cancer Institute, Boston, Massachusetts., Divito SJ; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Larocca C; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts. |
